Sex differences in use of potentially teratogenic disease modifying treatments for multiple sclerosis and degree of hormonal contraception overlap in women between 2007–2021: An Australian population-based study
Sex and age differences in DMT utilisation were observed based on teratogenic potential. Hormonal LARC overlap appears higher in those receiving potentially teratogenic DMTs, but overall rates remain low.
Authors
- Jeannette Lechner‐Scott (ORCID: https://orcid.org/0000-0002-3850-447X)
- Alice Rumbold (ORCID: https://orcid.org/0000-0002-4453-9425)
- Jenni Ilomäki (ORCID: https://orcid.org/0000-0002-0348-9441)
- Kelly Hall (ORCID: https://orcid.org/0000-0002-0171-3972)
- Anna Fragkoudi (ORCID: https://orcid.org/0000-0001-7660-7835)
- Luke E. Grzeskowiak (ORCID: https://orcid.org/0000-0001-8554-4696)
Institutions
- Flinders University (AU)
- John Hunter Hospital (AU)
- Hunter Medical Research Institute (AU)
- South Australian Health and Medical Research Institute (AU)
- Monash University (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1016/j.msard.2024.105937
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Channel 7 Children's Research Foundation
- University of Adelaide